Clinical trial
Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent…
NCT00103831 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00103831 |
|---|---|
| Title | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer |
| Official title | Phase I Alimta Combination With BMS-275183 (Oral Taxane) |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Oral Taxane |
| Primary completion | May 1, 2005 |
| First posted | Feb 16, 2005 |
| Last update posted | Mar 2, 2010 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: